Correlation Between Pfizer and Relief Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pfizer and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Relief Therapeutics Holding, you can compare the effects of market volatilities on Pfizer and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Relief Therapeutics.
Diversification Opportunities for Pfizer and Relief Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pfizer and Relief is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Relief Therapeutics go up and down completely randomly.
Pair Corralation between Pfizer and Relief Therapeutics
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.26 times more return on investment than Relief Therapeutics. However, Pfizer Inc is 3.82 times less risky than Relief Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about -0.18 per unit of risk. If you would invest 2,599 in Pfizer Inc on December 28, 2024 and sell it today you would lose (98.00) from holding Pfizer Inc or give up 3.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.36% |
Values | Daily Returns |
Pfizer Inc vs. Relief Therapeutics Holding
Performance |
Timeline |
Pfizer Inc |
Relief Therapeutics |
Pfizer and Relief Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Relief Therapeutics
The main advantage of trading using opposite Pfizer and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Relief Therapeutics vs. BBB Foods | Relief Therapeutics vs. Natural Alternatives International | Relief Therapeutics vs. The Gap, | Relief Therapeutics vs. Romana Food Brands |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges |